Go to Citation CrossrefPubMedWeb of ScienceGoogle Scholar 72
Human trials also report improvements in cholesterol levels, liver enzymes, and blood pressure, which are closely tied to excess weight and long-term metabolic strain
Cost and accessibility GLP-1RA is expensive, which limits its popularity in low-income countries and regions
Journal of Anti-Aging Medicine, 4(2), 133-144
Mounjaro/Zepbound (tirzepatide), approved dual GLP-1/GIP agonist for type 2 diabetes and obesity Recent Highlights: In April 2026, the FDA approved orforglipron (Foundayo), making it one of the first oral GLP-1 pills that can be taken any time of day and that has no food or water restrictions
Skin & collagen support GHK-Cu researched in cosmetic and preclinical work on collagen and skin repair